首页 | 本学科首页   官方微博 | 高级检索  
     


A dose-response study of phenylephrine in critically ill, septic surgical patients
Authors:L. Flancbaum  M. Dick  J. Dasta  R. Sinha  P. Choban
Affiliation:(1) Department of Surgery, The Ohio State University, 410 West 10th Ave., Columbus, OH 43210, USA, US;(2) Department of Anesthesiology, The Ohio State University, Columbus, OH 43210, USA, US;(3) Department of Emergency Medicine, The Ohio State University, Columbus, OH 43210, USA, US;(4) College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA, US
Abstract:Objective: To determine the response of haemodynamic and oxygen-transport parameters to phenylephrine in a dose-response fashion in septic non-hypotensive, vasodilated surgical intensive care unit (ICU) patients. Design: Prospective study. Setting: Surgical ICU of a tertiary care, university medical centre. Patients: Ten septic non-hypotensive, vasodilated surgical ICU patients. Interventions: Routine ICU monitoring, including pulmonary and radial artery catheters. Measurements: Haemodynamic and oxygen-transport measurements were taken at baseline and during therapy. Phenylephrine was infused intravenously for 3 h at progressively increasing doses of 0.5, 1.0, 2.0, 3.0, 4.0, and 8.0 μg · kg−1 · min−1 at 30-min intervals. Measurements were taken after each dose. Results: Mean arterial pressure (MAP) and systemic vascular resistance (SVRI) increased linearly with phenylephrine dose. Cardiac index and pulmonary artery occlusion pressures did not change. Statistically significant changes were observed in heart rate, MAP, stroke index, and systemic and pulmonary vascular resistance. Eight patients had a clinically significant increase (>15%) in oxygen consumption (VO2I). Oxygen delivery (D2OI) increased in only three patients. Serum lactate concentrations were unchanged or lower at the end of the study in all eight pateints, who displayed a 15% increase in VO2I. Conclusions: Treatment with phenylephrine increased expected haemodynamic parameters in a linear fashion; however, clinical changes in VO2I occurred at variable doses. Dose-response trials are needed to determine the optimal dose of phenylephrine. Further study is needed to evaluate the clinical effects of phenylephrine in septic patients. Received: 12 December 1995 / Accepted in revised form: 19 August 1996
Keywords:Phenylephrine  Septicaemia   vasopressors  alpha-adrenoceptor agonist  haemodynamics  blood pressure  critical illness  oxygen consumption
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号